• Centre for Primary Care and Public Health
• Clinical effectiveness group
• Pragmatic clinical trials unit
  • Who are we
  • What we do
  • Support available
  • Obtaining support
  • Staff role definitions
  • Responsibility of the chief investigator
  • Methodology
  • Standard operating procedures
  • Current projects
    • ASAP
    • BELLA
    • Body psychotherapy
    • Calcitriol
    • COPERS
    • DIALECT
    • EMPIRE
    • EPOS
    • FIAT
    • HiLo
    • IRIS
    • LEZ
    • MEDEA
    • Music therapy
    • NESS
    • OEDIPUS
    • OPERA
    • OViD
    • PREP
    • RHIVA 2
    • SNS vs PTNS Pilot
    • TOPAS
    • WAIT
  • Completed projects
  • Resources
  • News
  • Contact us
• Education and training
• Research design service
• Staff
• Research
• News and events
• IT Support
• Site map

WAIT

Wheeze And Intermittent Treatment: parent-determined oral montelukast therapy for preschool wheeze with stratification for arachidonate-5-lipoxygenase (ALOX5) promoter genotype.

Chief Investigator

Professor Jonathan Grigg

Chief investigator employing organisation

Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry

Status

Ongoing 

Details

Main publications 

None currently available.

Contact details

Centre for Paediatrics,
Institute of Cell and Molecular Science,
Barts and The London School of Medicine and Dentistry,
The Blizard Building, 4 Newark Street,
Whitechapel,
London E1 2AT

Email: j.grigg@qmul.ac.uk